dual gip/glp-1 receptor agonist Science Behind GLP 1 GIP and Glucagon Agonists for Obesity Research | News & Announcements PDF] Novel dual GLP-1/GIP receptor

supporting quicker impacts on health and wellbeing

Common adverse effectsnausea, vomiting, diarrheatypically diminish with gradual dose titration

Systemic effects of GLP-1 RAs, mediated via GLP-1 receptors in other organs and systems, include enhanced endothelial function and myocardial metabolism, natriuresis and anti-inflammatory and blood pressure-lowering effects

It comes as a pre-filled, single-use pen , requiring no mixing or dose adjustment

Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al

GLP-1RA as an independent class of drug is also noteworthy in reduction of weight in patients with and without poor glycaemic control with multiple trials backing the efficacy of agents including semaglutide and liraglutide (116)